drugset / Trial / NCT01738282
Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to assess the efficacy of Xylka® (baclofen) compared to placebo on continuous abstinence rate during 20 weeks of treatment, after withdrawal, in alcohol dependent patients receiving Brenda therapy sessions.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baclofen | Small molecule | 180 mg | — |